In gynecology, cardiotoxicity is a concern primarily in the context of cancer treatment. Drugs such as doxorubicin and trastuzumab, frequently used in the management of breast cancer and ovarian cancer, can cause significant cardiovascular side effects. These side effects can range from mild arrhythmias to severe heart failure.
